Christophe Fruchart Selected Research

FAM protocol

1/2004

A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christophe Fruchart Research Topics

Disease

12	Lymphoma (Lymphomas) 03/2022 - 10/2005
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 05/2011
5	B-Cell Lymphoma (Lymphoma, B Cell) 03/2022 - 01/2017
5	Neoplasms (Cancer) 01/2022 - 01/2018
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 08/2011
4	Neutropenia 01/2018 - 01/2004
2	Fatigue 01/2020 - 01/2020
2	Multiple Myeloma 09/2014 - 01/2010
1	Hyperglycemia 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Febrile Neutropenia 01/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 12/2016
1	Disease Progression 12/2016
1	Pathologic Complete Response 12/2014
1	Primary Ovarian Insufficiency 01/2012
1	Hodgkin Disease (Hodgkin's Disease) 01/2012
1	Thrombocytopenia (Thrombopenia) 01/2004
1	Leukopenia 01/2004
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2004

Drug/Important Bio-Agent (IBA)

12	Rituximab (Mabthera)FDA Link 03/2022 - 05/2011
7	Lenalidomide (CC 5013)FDA Link 01/2022 - 09/2014
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2020 - 01/2012
4	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017 - 05/2011
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2017 - 05/2011
4	Vincristine (Oncovin)FDA LinkGeneric 08/2017 - 05/2011
4	Prednisone (Sone)FDA LinkGeneric 08/2017 - 05/2011
3	obinutuzumabIBA 01/2022 - 01/2019
2	Bendamustine Hydrochloride FDA Link 10/2018 - 12/2016
2	Melphalan (Alkeran)FDA LinkGeneric 12/2014 - 01/2010
2	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2014 - 01/2004
2	Bortezomib (Velcade)FDA Link 09/2014 - 01/2010
1	SaltsIBA 03/2022
1	ibrutinibIBA 03/2022
1	PlatinumIBA 03/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 03/2022
1	copanlisibIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	ofatumumab FDA Link 01/2017
1	Yttrium-90IBA 12/2014
1	Etoposide (VP 16)FDA LinkGeneric 12/2014
1	ibritumomab tiuxetan (Zevalin)FDA Link 12/2014
1	Carmustine (FIVB)FDA Link 12/2014
1	Drug CombinationsIBA 09/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2013
1	factor AIBA 05/2013
1	AnthracyclinesIBA 01/2012
1	Monoclonal AntibodiesIBA 11/2011
1	InterferonsIBA 08/2011
1	Gallium-67IBA 12/2006
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2004
1	Arabinofuranosylcytosine TriphosphateIBA 01/2004
1	NucleotidesIBA 01/2004
1	fludarabineIBA 01/2004
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2004

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2022 - 01/2004
7	Therapeutics 01/2022 - 08/2011
5	Stem Cell Transplantation 03/2022 - 01/2004
2	Immunotherapy 01/2018 - 01/2018
1	Induction Chemotherapy 01/2020
1	BEAM regimen 12/2014
1	Transplantation 09/2014
1	VAP-cyclo protocol 05/2013
1	Salvage Therapy 08/2011
1	Combination Drug Therapy (Combination Chemotherapy) 01/2004
1	FAM protocol 01/2004